| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| A998709 | Anti-FGFR2 / CD332 Reference Antibody (bemarituzumab), Anti-FGFR2 / CD332 Reference Antibody (bemarituzumab), |
|||
| A998710 | Anti-FGFR3 / CD333 Reference Antibody (LY3076226), Anti-FGFR3 / CD333 Reference Antibody (LY3076226), |
|||
| A998711 | Anti-FGFR3 / CD333 Reference Antibody (vofatamab), Anti-FGFR3 / CD333 Reference Antibody (vofatamab), |
|||
| A998712 | Anti-FGFR4 / CD334 Reference Antibody (U3-1784), Anti-FGFR4 / CD334 Reference Antibody (U3-1784), |
|||
| A998713 | Anti-Fibronectin Reference Antibody (L19-TNF), Anti-Fibronectin Reference Antibody (L19-TNF), |
|||
| A998714 | Anti-Fibronectin Reference Antibody (radretumab), Anti-Fibronectin Reference Antibody (radretumab), |
|||
| A998715 | Anti-FLT3 / CD135 Reference Antibody (IMC-EB10), Anti-FLT3 / CD135 Reference Antibody (IMC-EB10), |
|||
| A998716 | Anti-FOLH1 / PSMA Reference Antibody (pelgifatamAb), Anti-FOLH1 / PSMA Reference Antibody (pelgifatamAb), |
|||
| A998717 | Anti-FOLH1 / PSMA Reference Antibody (rosopatamab), Anti-FOLH1 / PSMA Reference Antibody (rosopatamab), |
|||
| A998718 | Anti-FOLR1 Reference Antibody (Dompe patent anti-FOLR1), Anti-FOLR1 Reference Antibody (Dompe patent anti-FOLR1), |
|||
| A998719 | Anti-FOLR1 Reference Antibody (farletuzumab), Anti-FOLR1 Reference Antibody (farletuzumab), |
|||
| A998720 | Anti-FOLR1 Reference Antibody (mirvetuximab), Anti-FOLR1 Reference Antibody (mirvetuximab), |
|||
| A998721 | Anti-Fucosyl GM1 Reference Antibody (BMS-986012), Anti-Fucosyl GM1 Reference Antibody (BMS-986012), |
|||
| A998722 | Anti-FZD Reference Antibody (vantictumab), Anti-FZD Reference Antibody (vantictumab), |
|||
| A998723 | Anti-FZD10 Reference Antibody (tabituximab), Anti-FZD10 Reference Antibody (tabituximab), |
|||
| A998724 | Anti-FZD7 Reference Antibody (U.Toronto patent anti-FZD7), Anti-FZD7 Reference Antibody (U.Toronto patent anti-FZD7), |
|||
| A998725 | Anti-GAD65 Reference Antibody (U.Washington patent anti-GAD65), Anti-GAD65 Reference Antibody (U.Washington patent anti-GAD65), |
|||
| A998726 | Anti-GCGR Reference Antibody (crotedumab), Anti-GCGR Reference Antibody (crotedumab), |
|||
| A998727 | Anti-GCGR Reference Antibody (volagidemab), Anti-GCGR Reference Antibody (volagidemab), |
|||
| A998728 | Anti-GD2 Reference Antibody (dinutuximab), Anti-GD2 Reference Antibody (dinutuximab), |